Literature DB >> 8061374

Outcome statistics of renal transplants with an emphasis on long-term survival.

J M Cecka1.   

Abstract

Remarkable increases in cadaveric renal transplant survival rates have been seen following improvements in areas such as immunosuppression, organ preservation, HLA typing and cross-matching, and blood transfusion protocols. However, while these improvements have influenced survival in the early post-transplant period up to 6 months, the cumulative rate of graft loss beyond the 1st year has remained constant at about 9% a year over the past 25 years. Several factors that affect long-term survival have been identified through univariate and multivariate analyses. Chief among these is the detrimental effect of HLA-A and HLA-B antigen mismatching. Also important are the recipient's race, sex, and age, and presence of diabetes, as well as the donor's age, sex, and cause of death, and long cold ischemia times. Likewise, post-transplant events, including delayed graft function, early rejection episodes, and discharge serum creatinine levels strongly affect long-term graft survival. Chronic rejection should also be recognized as a major contributor to the long-term failure rate, but there is currently no reliable way to identify or classify it in the UNOS Scientific Renal Transplant Registry database. Characteristics that define chronic rejection must be identified to allow transplant centers to accurately report its incidence and to enable investigators to analyze and monitor its impact on transplant outcome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061374

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

1.  EGF and TGF-beta1 gene expression in chronically rejecting small bowel transplants.

Authors:  E A Kouwenhoven; A N Stein-Oakley; P Jablonski; R W de Bruin; N M Thomson
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

2.  Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK.

Authors:  Phil McEwan; Simon Dixon; Keshwar Baboolal; Pete Conway; Craig J Currie
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Eotaxin and capping protein in experimental vasculopathy.

Authors:  J Chen; L M Akyürek; B Fellström; P Häyry; L C Paul
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

Review 4.  Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation.

Authors:  A Tarantino; G Montagnino; C Ponticelli
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.